[1] STRATTON M R,CAMPBELL P J,FUTREAL P A.The cancer genome[J].Nature,2009,458(7239):719-724.
[2] DING L,WENDL M C,McMICHAEL J F,et al.Expanding the computational toolbox for mining cancer genomes[J].Nat Rev Genet,2014,15(8):556-570.
[3] STEPHENS P J,TARPEY P S,DAVIES H,et al.The landscape of cancer genes and mutational processes in breast cancer[J].Nature 2012,486(7403):400-404.
[4] FORBES S A,BHAMRA G,BAMFORD S,et al.The catalogue of somatic mutations in cancer(COSMIC)[J/OL].Curr Protoc Hum Genet,2008.doi:10.1002/0471142905.hg1011s57
[5] DAVIES C,TOURNIER C.Exploring the function of the jnk(c-jun n-terminal kinase)signalling pathway in physiological and pathological processes to design novel therapeutic strategies[J].Biochem Soc Trans,2012,40(1):85-89.
[6] ANGEL P,HATTORI K,SMEAL T,et al.The jun proto-oncogene is positively autoregulated by its product,jun/ap-1[J].Cell,1988,55(5):875-885.
[7] PARK H S,KIM M S,HUH S H,et al.Akt(protein kinase b)negatively regulates SEK1 by means of protein phosphorylation[J].J Biol Chem,2002,277(4):2573-2578.
[8] PEROU C M,SORLIE T,EISEN M B,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
[9] EROLES P,BOSCH A,PEREZ-FIDALGO J A,et al.Molecular biology in breast cancer:intrinsic subtypes and signaling pathways[J].Cancer Treat Rev,2012,38(6):698-707.
[10] BANERJI S,CIBULSKIS K,RANGEL-ESCARENO C,et al.Sequence analysis of mutations and translocations across breast cancer subtypes[J].Nature,2012,486(7403):405-409.
[11] SPECK N A.Core binding factor and its role in normal hematopoietic development[J].Curr Opin Hematol,2001,8(4):192-196.
[12] YOSHIDA C A,FURUICHI T,FUJITA T,et al.Core-binding factor beta interacts with Runx2 and is required for skeletal development[J].Nat Genet,2002,32(4):633-638.
[13] CHIMGE N O,FRENKEL B.The runx family in breast cancer:relationships with estrogen signaling[J].Oncogene,2012,32(17):2121-2130.
[14] Cancer Genome Atlas Network.Comprehensive molecular portraits of human breast tumours[J].Nature,2012,490(7418):61-70.
[15] ALEXANDROV L B,NIK-ZAINAL S,WEDGE D C,et al.Signatures of mutational processes in human cancer[J].Nature,2013,500(7463):415-421.
[16] ROYCHOWDHURY S,CHINNAIYAN A M.Translating genomics for precision cancer medicine[J].Ann Rev Genom Hum Genet,2014,15:395-415.
[17] NIK-ZAINAL S,ALEXANDROV L B,WEDGE D C,et al.Mutational processes molding the genomes of 21 breast cancers[J].Cell,2012,149(5):979-993.
[18] DING L,ELLIS M J,LI S,et al.Genome remodelling in a basal-like breast cancer metastasis and xenograft[J].Nature,2010,464(7291):999-1005.
[19] SHAH S P,MORIN R D,KHATTRA J,et al.Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution[J].Nature,2009,461(7265):809-813.
[20] MCCART REED A E,KUTASOVIC J R,LAKHANI S R,et al.Invasive lobular carcinoma of the breast:morphology,biomarkers and omics[J].Breast Cancer Res,2015,17:12.
[21] RAKHA E A,REIS-FILHO J S,ELLIS I O.Basal-like breast cancer:a critical review[J].J Clin Oncol,2008,26(15):2568-2581.
[22] WELCKER M,CLURMAN B E.FBW7 ubiquitin ligase:a tumour suppressor at the crossroads of cell division,growth and differentiation[J].Nat Rev Cancer,2008,8(2):83-93.
[23] BAJPAI S,FENG Y,KRISHNAMURTHY R,et al.Loss of alpha-catenin decreases the strength of single e-cadherin bonds between human cancer cells[J].J Biol Chem,2009,284(27):18252-18259.
[24] PLUMB C L,ADAMCIC U,SHAHRZAD S,et al.Modulation of the tumor suppressor protein alpha-catenin by ischemic microenvironment[J].Am J Pathol,2009,175(4):1662-1674.
[25] WANG Y,NAVIN N E.Advances and applications of single-cell sequencing technologies[J].Mol Cell,2015,58(4):598-609.
[26] NAVIN N,KENDALL J,TROGE J,et al.Tumour evolution inferred by single-cell sequencing[J].Nature,2011,472(7341):90-94.
[27] WANG Y,WATERS J,LEUNG M L,et al.Clonal evolution in breast cancer revealed by single nucleus genome sequencing[J].Nature,2014,512(7513):155-160. |
